To describe the evolution of trough drug dose-normalized plasma concentrations before and after Roux-en-Y gastric bypass (RYGB) in patients treated with antidepressants, emphasizing the importance of monitoring these levels post-surgery.
Key Findings:
Significant decreases in plasma concentrations of sertraline, mirtazapine, duloxetine, and citalopram post-RYGB, indicating a need for dosage adjustments.
A decline in plasma escitalopram concentrations was observed in all patients after RYGB, necessitating careful monitoring.
Initial decrease in antidepressant concentrations followed by normalization or increase at 6 to 12 months post-surgery, suggesting variability in patient responses.
Interpretation:
The findings suggest that RYGB significantly alters the pharmacokinetics of antidepressants, necessitating careful monitoring and potential dosage adjustments to ensure effective treatment.
Limitations:
Small sample size and case series design limit generalizability, and potential confounding factors may affect results.
Exclusion of patients who switched/stopped antidepressant medication may bias results.
Conclusion:
RYGB impacts the plasma concentrations of antidepressants, highlighting the need for ongoing monitoring and possible treatment adjustments in this patient population, and further research is warranted.
